Loading company details...
Beta
Latest Form 4 (Sep 8, 2026): Carmine N. Stengone (CEO and President): Exercise/Conversion of 2,500 shares, $2.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 8, 2026 | Carmine N. Stengone, CEO and President | Exercise/Conversion | 2,500 | $2.5K |
| Aug 3, 2026 | Carmine N. Stengone, CEO and President | Exercise/Conversion | 2,500 | $2.5K |
| Jul 10, 2026 | Daniel S. Lorrain, Chief Scientific Officer | Exercise/Conversion | 1,015 | $1.0K |
| Jul 8, 2026 | Carmine N. Stengone, CEO and President | Exercise/Conversion | 2,500 | $2.5K |
| Jul 2, 2026 | Daniel S. Lorrain, Chief Scientific Officer | Exercise/Conversion | 28,826 | $29.1K |
| Jul 1, 2026 | Tim Watkins, CMO & Head of Development | Exercise/Conversion | 10,833 | $48.7K |
| Jul 1, 2026 | Carmine N. Stengone, CEO and President | Exercise/Conversion | 7,500 | $7.6K |
| Jun 26, 2026 | Gines Diego Miralles | Grant/Award | 19,000 | n/a |
| Jun 26, 2026 | Lori Lyons-Williams | Grant/Award | 19,000 | n/a |
| Jun 26, 2026 | Olivia C. Ware | Grant/Award | 19,000 | n/a |